Top Trends per Segment in the U.S. Neurological Device Market

U.S. neurological devices: Medtronic Intellis Platform™
Medtronic’s Intellis Platform™, retrieved from

Neuromodulation, neurovascular, and neurosurgical devices collectively make up iData’s U.S. neurological devices market report. Within the United States, the overall neurological device market is growing and our analysts expect it to continue the substantial growth pattern into 2026. The categories included within the U.S. neurological device market report include: 

  • Cerebrospinal Fluid Management 
  • Interventional Neuroradiology 
  • Neuromodulation 
  • Neurosurgery 
  • Neurovascular Thrombectomy 

All of which further segment into specific markets such as the detachable coil market, liquid embolic market, neurovascular catheter market, and more. Overall, each segment other than the aneurysm clip market is experiencing growth. Although the majority of segments are seeing increased demand, different factors are at play. Below, the top market trends within each sector of the U.S. neurological device market are listed. If you’re curious to see where the market is heading, keep on reading.


Devices in the cerebrospinal fluid (CSF) management market are used for the treatment of hydrocephalus. Hydrocephalus refers to an abnormal buildup of CSF in the ventricles. One major trend within this market is the shift towards pressure adjustable valves. Otherwise known as programmable valves, they are becoming popular as surgeons appreciate the ability to control and adjust the settings of these valves for each individual patient. However, these devices cost a premium. Therefore, their increasing popularity will continue to drive market growth.


Over the past several years, there has been a transition in interventional neuroradiology from surgical to endovascular techniques. This has caused a conversion from aneurysm clipping to endovascular coiling and, more recently, flow diverting. However, procedure volume for endovascular clipping is slowing down as neurovascular stents increase in adoption. Since the FDA expanded the indications for Medtronic’s Pipeline Flex to include small or medium aneurysms, the market has experienced double-digit growth. Therefore, a top trend within this segment surrounds the shift towards neurovascular stents.


The U.S. neuromodulation market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), gastric electric stimulation (GES), dorsal root ganglion (DRG) stimulation, and responsive neurostimulation (RNS). One major trend within the neuromodulation market is the increased popularity surrounding deep brain stimulation (DBS). With a growing list of indications, DBS is the fastest-growing segment. Approximately 1 million individuals in the U.S. have drug-resistant epilepsy. Because DBS therapy can be used to treat epilepsy, the market is increasing rapidly. 


Within the U.S. neurological devices market, the neurosurgery category encompasses the following segments: stereotactics and ultrasonic aspirators. Within the U.S. neurosurgery market, doctors are shifting towards stereotactic neurosurgery. Stereotactic neurosurgery traditionally removes brain tumors and performs brain biopsies. However, stereotactic surgery has been trending towards implant electrodes in deep brain stimulation, which treats chronic pain, Parkinson’s disease, tremor, and dystonia. The increasing popularity of deep brain stimulation therapy has been one of the primary drivers of the stereotactic system market over the last three years. 


Thrombectomy devices include stent retrievers and aspiration catheters, which remove blood vessel blockages. Within the last few years, the attention surrounding ischemic strokes has increased. However, in the past, less than half of the emergency hospitals in the U.S. have certified stroke centers. Therefore previously, the patients needed to be transported to different hospitals, causing them to lose valuable time. Currently, over 800 hospitals are now certified stroke centers, increasing the need for thrombectomy devices. Because of this, one major trend within the U.S. neurovascular thrombectomy market is increased usage of aspiration catheters which are seeing a double-digit demand growth into 2026. 


For more information on unit sales, average selling prices (ASPs), procedures, competitive analyses, and more follow the link below to receive a free market synopsis for the U.S. Neurological Devices report. Additionally, iData offers reports on the Global and European markets for Neurological devices which include all of the segments discussed above.


See the full Executive Summary


Leave a Reply